MedTrace Logo

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

NCT02099682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3366

Last updated 2016-11-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin

Conditions

  • Gastric or Duodenal Ulcers

Interventions

DRUG

Lansoprazole

Lansoprazole Capsules 15/ OD Tablets

Sponsors & Collaborators

Principal Investigators

  • Postmarketing Group Manager · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2014-01-31
Completion
2014-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099682 on ClinicalTrials.gov